Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
Gynecologic Oncology
|
July 6, 2021
Optimization of postoperative opioid prescriptions in gynecologic oncology: Striking a balance between opioid reduction and pain control
Alli M Straubhar, Liam Dalton, Aimee Rolston, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Avoidable admissions after minimally invasive hysterectomy
Amanda Manorot, Shitanshu Uppal, Olivia de Bear, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 9, 2024
Avoidable admissions after minimally invasive hysterectomy
Amanda Manorot, Shitanshu Uppal, Olivia de Bear, et al.
Journal of Translational Medicine
|
June 24, 2009
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
Heather L Pulaski, Gregory Spahlinger, Ines A Silva, et al.
Obstetrics and Gynecology
|
March 5, 2016
Prophylactic Antibiotic Choice and Risk of Surgical Site Infection After Hysterectomy
Shitanshu Uppal, John Harris, Ahmed Al-Niaimi, et al.
Cancer Research
|
April 19, 2011
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival
Ines A Silva, Shoumei Bai, Karen McLean, et al.
BMC Medical Education
|
February 19, 2016
Optimizing the post-graduate institutional program evaluation process
Monica L Lypson, Mark E P Prince, Steven J Kasten, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 13, 2008
Cervical cancer screening
Edward E Partridge, Nadeem Abu-Rustum, Susan Campos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 29, 2009
Cervical cancer screening clinical practice guidelines in oncology
Edward E Partridge, Nadeem R Abu-Rustum, Susana Campos, et al.
JCI Insight
|
May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
Jason R Brown, Daniel K Chan, Jessica J Shank, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
Gynecologic Oncology
|
July 6, 2021
Optimization of postoperative opioid prescriptions in gynecologic oncology: Striking a balance between opioid reduction and pain control
Alli M Straubhar, Liam Dalton, Aimee Rolston, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 14, 2025
Avoidable admissions after minimally invasive hysterectomy
Amanda Manorot, Shitanshu Uppal, Olivia de Bear, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
August 9, 2024
Avoidable admissions after minimally invasive hysterectomy
Amanda Manorot, Shitanshu Uppal, Olivia de Bear, et al.
Journal of Translational Medicine
|
June 24, 2009
Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
Heather L Pulaski, Gregory Spahlinger, Ines A Silva, et al.
Obstetrics and Gynecology
|
March 5, 2016
Prophylactic Antibiotic Choice and Risk of Surgical Site Infection After Hysterectomy
Shitanshu Uppal, John Harris, Ahmed Al-Niaimi, et al.
Cancer Research
|
April 19, 2011
Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival
Ines A Silva, Shoumei Bai, Karen McLean, et al.
BMC Medical Education
|
February 19, 2016
Optimizing the post-graduate institutional program evaluation process
Monica L Lypson, Mark E P Prince, Steven J Kasten, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 13, 2008
Cervical cancer screening
Edward E Partridge, Nadeem Abu-Rustum, Susan Campos, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 29, 2009
Cervical cancer screening clinical practice guidelines in oncology
Edward E Partridge, Nadeem R Abu-Rustum, Susana Campos, et al.
JCI Insight
|
May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer
Jason R Brown, Daniel K Chan, Jessica J Shank, et al.
Page
of 7